Good News For Women With Newly-Diagnosed Ovarian Cancer — A Significant Increase in Survival Time With Promising New PARP Inhibitor Drugs

Updated September 30th, 2019

Good News For Women With Newly-Diagnosed Ovarian Cancer — A Significant Increase in Survival Time With Promising New PARP Inhibitor Drugs

A specific PARP inhibitor called Zejula more than doubled the amount of time that many women with ovarian cancer lived without their cancer getting worse.

NOW
PLAYING
Nene Leakes Husband Gregg Back Home After Colon Cancer Diagnosis
NOW
PLAYING
Beloved Atlanta News Anchor Jovita Moore Diagnosed with Glioblastoma
NOW
PLAYING
FDA: Risks to Myeloma Patients Taking Pepaxto After Deaths in Trial
NOW
PLAYING
Mark Hoppus Felt Terrible, Had 'Chemo Brain' After Last Cancer Treatment
NOW
PLAYING
Miranda McKeon Starts Losing Hair From Chemo in Breast Cancer Battle
NOW
PLAYING
Rick Aiello, Son of Actor Danny Aiello, Dies Aged 65 of Pancreatic Cancer

SurvivorNetTV.
Hope. Science.
Inspiration.

WATCH NOW
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.